SEEDNasdaqAgricultural Production-CropsUS GAAP · USD

Origin Agritech LTD

Origin Agritech LTD is a China-focused agricultural biotechnology company that develops, produces, processes, and commercializes crop varieties, with a particular emphasis on corn seed genetics. The company combines breeding, gene editing, seed production, and related technical services through its operations and research base in China.

Liikevaihto91,3milj. USD
−19,5 %v/v
Nettotulos−53,3milj. USD
−357,5 %v/v
Vapaa kassavirta−34,1milj. USD
−70,3 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2020–2025

0255075100125milj. USD2020: 53 milj. USD20202021: 46 milj. USD20212022: 53 milj. USD20222023: 93 milj. USD20232024: 113 milj. USD20242025: 91 milj. USD202591
LiikevaihtoLiikevoitto (EBIT)

Liiketoiminta

Osuus liikevaihdosta
Corn seed products55 %

Commercial corn seed varieties sold to farming customers and distribution partners.

Biotech seed traits20 %

Genetically modified and gene-edited traits embedded in proprietary seed lines.

Seed tolling and processing15 %

External seed processing and tolling services tied to seed manufacturing.

Technical services10 %

Agronomy, breeding, and product support services provided alongside seed sales.

Asiakkaat

The company sells primarily into the agricultural seed market in China, where buyers include farmers, agricultural distributors, and commercial growers seeking improved corn varieties. It also serves institutional and industry partners through breeding collaborations and technical services tied to product development and commercialization. Demand is driven by yield improvement, trait performance, local adaptation, and access to newer seed technologies.

Farmers and growers

Buy corn seed varieties for planting and yield improvement.

Seed distributors

Purchase seed products for resale through regional agricultural channels.

Commercial agriculture partners

Use proprietary seed lines and technical support for large-scale cultivation.

Research and breeding partners

Collaborate on genetics, breeding, and gene-editing programs.

Strategia

The company’s strategy is centered on commercializing new corn seed products and expanding the reach of its biotechnology platform. It is also rebuilding its sales network, upgrading seed manufacturing and supply chain capabilities, and strengthening organization and branding to support broader commercialization. Gene editing and market-oriented breeding are intended to shorten product-development cycles and better match customer demand.

Commercialize new corn seed varietiesLyhyt aikaväli

New products can improve market relevance and support seed revenue growth.

Rebuild sales channelsLyhyt aikaväli

A stronger sales network is needed to convert breeding output into market adoption.

Scale biotech and gene-editing platformKeskipitkä aikaväli

Proprietary traits can differentiate products and improve long-term competitive position.

Upgrade manufacturing and supply chainKeskipitkä aikaväli

Reliable seed production and processing are essential for commercialization and quality control.

Maantiede

Origin Agritech is centered in China, where its research, production, and commercialization activities are based. The company’s market exposure is primarily tied to Chinese agriculture and the timing of seed adoption, regulatory approvals, and commercial planting cycles. Its U.S. listing provides access to international capital markets, but the operating footprint and customer demand are concentrated in China.

Riskit

The business depends on successful product commercialization, regulatory approvals for genetically modified traits, and the ability to rebuild distribution in a competitive seed market. Because the company is concentrated in China, it is exposed to policy, agronomic, and channel risks that can affect seed adoption, inventory planning, and timing of revenue recognition. Research spending, tax matters, and execution on new product launches also create operating and accounting volatility.

Järjestetty vakavuuden mukaan
MatalaKohtalainenKorkeaMatalaKohtalainenKorkeaVaikutus →Todennäköisyys →Commercial adoption risk1Regulatory approval risk for biotech traits2China concentration risk3Execution risk in sales network rebuild4Tax and contingent liability risk5
Vaikutus on riskin vakavuus ja todennäköisyys sen toteutumisen todennäköisyys lähivuosina, molemmat arvioitu yhtiön raporttien perusteella. Numerot vastaavat listaa.
  1. Commercial adoption riskVaikutus: KorkeaTodennäköisyys: Korkea

    Revenue depends on farmers and distributors accepting new seed products and switching from established alternatives.

    Kohdistuu: New product sales and channel expansion

  2. Regulatory approval risk for biotech traitsVaikutus: KorkeaTodennäköisyys: Kohtalainen

    Commercialization of genetically modified and gene-edited seeds depends on biosafety and regulatory clearance.

    Kohdistuu: New corn traits and product pipeline

  3. China concentration riskVaikutus: KeskitasoTodennäköisyys: Korkea

    Operations, customers, and regulatory oversight are centered in China, increasing exposure to local market conditions.

    KohdistuuRevenueOperationsApprovals in China
  4. Execution risk in sales network rebuildVaikutus: KeskitasoTodennäköisyys: Korkea

    The company must rebuild distribution and marketing capabilities to support product commercialization.

    Kohdistuu: Go-to-market and seed distribution

  5. Tax and contingent liability riskVaikutus: KeskitasoTodennäköisyys: Kohtalainen

    Open tax years and uncertain tax positions can lead to future adjustments if authorities dispute filings.

    Kohdistuu: China tax examinations

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition

Seed sales, tolling services, and technical services may have different recognition timing and performance obligations.

Vaikutus: Can shift reported revenue between quarters

Research and development expense

Breeding and gene-editing programs require ongoing R&D that is expensed as incurred under US GAAP.

Vaikutus: Affects operating results and pipeline investment visibility

Inventory and production costs

Seed manufacturing and processing require inventory valuation and cost allocation judgments.

Vaikutus: Can influence margins and period comparability

Uncertain tax positions

Open tax years in China may lead to future assessments, penalties, or liability adjustments.

Vaikutus: Can create unexpected earnings and balance sheet changes

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Päivitetty: 28.9.2026

Origin Agritech LTD (Nasdaq) – Agricultural Production-Crops | Analyysi – Clarifo